From USFDA
Zydus Cadila has received final approval from USFDA to market Metronidazole Tablets USP in strengths of 250 mg and 500 mg. The drug which is used to treat infections caused by bacteria or parasite will be produced at the group's formulations manufacturing facility at Baddi.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
